Jun Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jun Meng has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Chang-He Ding
8 shared publicationsYue Meng
College of Food Science and Engineering Henan University of Technology Zhengzhou China
8 shared publicationsJun Xi
7 shared publicationsYun-Peng Hao
6 shared publicationsXiang-Ge Xin
3 shared publicationsYan-Yang Wang
College of Food Science and Engineering, Henan University of Technology, Zhengzhou, China
3 shared publications
Latest Publications
- 27 August 2026
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 107 (1) , 669-684
The ameliorative effects of fermented Xinjiang jujube juice by Lactiplantibacillus plantarum GD 03 on iron‐deficiency anemia
BACKGROUND: Jujube is renowned for its iron‐supplementing and anti‐anemic properties. This research aimed to investigate the influence of Lactiplantibacillus plantarum GD 03 fermentation on the nutritional components of Xinjiang jujube juice, and further to explore the ameliorative effects of fermented jujube juice on iron‐deficiency anemia (IDA). RESULTS: The results demonstrated that Lactiplantibacillus plantarum fermentation significantly increased the content of total flavonoid and the levels of trace elements (Fe: 390.59%, Ca: 26.32%, K: 25.92%, Mg: 10.81%) in jujube juice, while reducing the content of phytic acid. In vivo experiments showed that compared to the model group (MG), high‐dose fermented jujube juice (HDF) significantly elevated the levels of serum iron and tissue iron in IDA mice, and reduced the total iron‐binding capacity and transferrin in the liver, spleen, and serum. Also, HDF enhanced the antioxidant capacity in tissues, and regulated the inflammatory cytokines (IL‐6 and TNF‐ α decreased, IL‐10 increased) in tissues and serum. Additionally, HDF alleviated IDA‐induced organ enlargement and hepatocyte damage. Gut microbiota analysis revealed that HDF promoted the abundance of beneficial bacteria and reduced the proportion of pathogenic bacteria. Compared to the MG group, the contents of acetic acid, propanoic acid, and butyric acid in the intestine of the HDF group were increased 2–3 times, while isobutyric acid, isovaleric acid, and valeric acid were decreased significantly. CONCLUSION: All the findings indicated that Lactiplantibacillus plantarum fermented jujube juice effectively improved IDA symptoms, providing a theoretical basis for developing jujube‐based functional foods to address IDA. © 2026 Society of Chemical Industry.
- 27 August 2026
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 107 (1) , 669-684
The ameliorative effects of fermented Xinjiang jujube juice by Lactiplantibacillus plantarum GD 03 on iron‐deficiency anemia
BACKGROUND: Jujube is renowned for its iron‐supplementing and anti‐anemic properties. This research aimed to investigate the influence of Lactiplantibacillus plantarum GD 03 fermentation on the nutritional components of Xinjiang jujube juice, and further to explore the ameliorative effects of fermented jujube juice on iron‐deficiency anemia (IDA). RESULTS: The results demonstrated that Lactiplantibacillus plantarum fermentation significantly increased the content of total flavonoid and the levels of trace elements (Fe: 390.59%, Ca: 26.32%, K: 25.92%, Mg: 10.81%) in jujube juice, while reducing the content of phytic acid. In vivo experiments showed that compared to the model group (MG), high‐dose fermented jujube juice (HDF) significantly elevated the levels of serum iron and tissue iron in IDA mice, and reduced the total iron‐binding capacity and transferrin in the liver, spleen, and serum. Also, HDF enhanced the antioxidant capacity in tissues, and regulated the inflammatory cytokines (IL‐6 and TNF‐ α decreased, IL‐10 increased) in tissues and serum. Additionally, HDF alleviated IDA‐induced organ enlargement and hepatocyte damage. Gut microbiota analysis revealed that HDF promoted the abundance of beneficial bacteria and reduced the proportion of pathogenic bacteria. Compared to the MG group, the contents of acetic acid, propanoic acid, and butyric acid in the intestine of the HDF group were increased 2–3 times, while isobutyric acid, isovaleric acid, and valeric acid were decreased significantly. CONCLUSION: All the findings indicated that Lactiplantibacillus plantarum fermented jujube juice effectively improved IDA symptoms, providing a theoretical basis for developing jujube‐based functional foods to address IDA. © 2026 Society of Chemical Industry.
- 8 August 2026
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 177
Bacterial surface interfaces in food systems: a programmable regulatory layer
- 8 August 2026
- Published by Elsevier in Trends in Food Science & Technology
- Vol. 177
Bacterial surface interfaces in food systems: a programmable regulatory layer
- 13 February 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 350, 150925
The dual role of teichoic acids in gram-positive bacteria: Structural diversity dictates pathogenic and probiotic functions
- 13 February 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 350, 150925
The dual role of teichoic acids in gram-positive bacteria: Structural diversity dictates pathogenic and probiotic functions
- 7 February 2026
- Published by Elsevier in Food Bioscience
- Vol. 77
Alleviating effects and mechanism of Lacticaseibacillus paracasei BHP06 on the allergic reactions induced by ovalbumin
- 7 February 2026
- Published by Elsevier in Food Bioscience
- Vol. 77
Alleviating effects and mechanism of Lacticaseibacillus paracasei BHP06 on the allergic reactions induced by ovalbumin
- 17 December 2025
- Published by Elsevier in Food Bioscience
- Vol. 75
Precision screening of Lactobacillus with potential anti-allergenic using dual cell model
- 17 December 2025
- Published by Elsevier in Food Bioscience
- Vol. 75
Precision screening of Lactobacillus with potential anti-allergenic using dual cell model
- Open Access
- 19 November 2025
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 91 (11) , e0115225
The anti-obesity effects of Clostridium butyricum B-3 and its impact on gut microbiota
Obesity has emerged as a significant global health threat. In this study, we investigated the anti-obesity properties of Clostridium butyricum B-3, a strain noted for its high butyric acid production. This strain was administered to mice on a high-fat diet (HFD) to assess its potential anti-obesity effects. Our findings indicate that three different dosages of C. butyricum B-3 significantly ( P < 0.05) mitigated excessive weight gain and ameliorated kidney and liver damage in HFD mice. A medium dose (10 7 CFU/day) of C. butyricum B-3 markedly reduced levels of total cholesterol, triglycerides and low-density lipoprotein cholesterol, and elevated levels of high-density lipoprotein cholesterol in HFD mice. Additionally, this dosage lowered serum levels of inflammatory cytokines, including IL-6, IL-10, and TNF-α. Furthermore, treatment with C. butyricum B-3 enhanced the diversity and relative abundance of gut microbiota in HFD-fed mice. Notably, the gut microbiota composition of the high-dose (10 8 CFU/day) group closely resembled that of mice fed a normal diet. C. butyricum B-3 also significantly increased the concentrations of acetic acid, propionic acid, and butyric acid in the gut. In summary, C. butyricum B-3 demonstrated significant anti-obesity effects and the ability to regulate intestinal microbiota in HFD mice. IMPORTANCE: Obesity represents one of the most severe global health challenges of our time. Clostridium butyricum has recently been recognized as a next-generation probiotic with considerable potential for applications in intestinal health, metabolic diseases, and neuroprotection. Our research focused on a specific strain of C. butyricum known for its anti-obesity effects, which displayed robust capabilities in mitigating obesity and regulating intestinal flora. This strain holds significant promise for development in anti-obesity nutritional products and pharmaceuticals.
- 19 November 2025
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 91 (11) , e0115225
Open AccessThe anti-obesity effects of Clostridium butyricum B-3 and its impact on gut microbiota
Obesity has emerged as a significant global health threat. In this study, we investigated the anti-obesity properties of Clostridium butyricum B-3, a strain noted for its high butyric acid production. This strain was administered to mice on a high-fat diet (HFD) to assess its potential anti-obesity effects. Our findings indicate that three different dosages of C. butyricum B-3 significantly ( P < 0.05) mitigated excessive weight gain and ameliorated kidney and liver damage in HFD mice. A medium dose (10 7 CFU/day) of C. butyricum B-3 markedly reduced levels of total cholesterol, triglycerides and low-density lipoprotein cholesterol, and elevated levels of high-density lipoprotein cholesterol in HFD mice. Additionally, this dosage lowered serum levels of inflammatory cytokines, including IL-6, IL-10, and TNF-α. Furthermore, treatment with C. butyricum B-3 enhanced the diversity and relative abundance of gut microbiota in HFD-fed mice. Notably, the gut microbiota composition of the high-dose (10 8 CFU/day) group closely resembled that of mice fed a normal diet. C. butyricum B-3 also significantly increased the concentrations of acetic acid, propionic acid, and butyric acid in the gut. In summary, C. butyricum B-3 demonstrated significant anti-obesity effects and the ability to regulate intestinal microbiota in HFD mice. IMPORTANCE: Obesity represents one of the most severe global health challenges of our time. Clostridium butyricum has recently been recognized as a next-generation probiotic with considerable potential for applications in intestinal health, metabolic diseases, and neuroprotection. Our research focused on a specific strain of C. butyricum known for its anti-obesity effects, which displayed robust capabilities in mitigating obesity and regulating intestinal flora. This strain holds significant promise for development in anti-obesity nutritional products and pharmaceuticals.
- 5 January 2025
- Published by Elsevier in Food Bioscience
- Vol. 63
Antibacterial capacity and mechanism of the metabolites from two vaginal Lactobacillus strains
- 5 January 2025
- Published by Elsevier in Food Bioscience
- Vol. 63
Antibacterial capacity and mechanism of the metabolites from two vaginal Lactobacillus strains
- Open Access
Characteristics of Citrate-Esterified Starch and Enzymatically Debranched Starch and Their Effects on Diabetic Mice
Chickpea has significant benefits as an adjuvant treatment for type 2 diabetes mellitus (T2DM). The properties of chickpea resistant starches (RSs) and their abilities to reduce T2DM symptoms and control intestinal flora were investigated. The RS content in citrate-esterified starch (CCS; 74.18%) was greater than that in pullulanase-modified starch (enzymatically debranched starch (EDS); 38.87%). Compared with those of native chickpea starch, there were noticeable changes in the granular structure and morphology of the two modified starches. The CCS showed surface cracking and aggregation. The EDS particles exhibited irregular layered structures. The expansion force of the modified starches decreased. The CCS and EDS could successfully lower blood glucose, regulate lipid metabolism, lower the levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), reduce the expressions of interleukin-6 (IL-6) and interleuki n-10 (IL-10), and decrease diabetes-related liver damage. Moreover, the CCS and EDS altered the intestinal flora makeup in mice with T2DM. The abundance of Bacteroidota increased. Both types of chickpea RSs exhibited significant hypoglycaemic and hypolipidaemic effects, contributing to the reduction in inflammatory levels and the improvement in gut microbiota balance.
Open AccessCharacteristics of Citrate-Esterified Starch and Enzymatically Debranched Starch and Their Effects on Diabetic Mice
Chickpea has significant benefits as an adjuvant treatment for type 2 diabetes mellitus (T2DM). The properties of chickpea resistant starches (RSs) and their abilities to reduce T2DM symptoms and control intestinal flora were investigated. The RS content in citrate-esterified starch (CCS; 74.18%) was greater than that in pullulanase-modified starch (enzymatically debranched starch (EDS); 38.87%). Compared with those of native chickpea starch, there were noticeable changes in the granular structure and morphology of the two modified starches. The CCS showed surface cracking and aggregation. The EDS particles exhibited irregular layered structures. The expansion force of the modified starches decreased. The CCS and EDS could successfully lower blood glucose, regulate lipid metabolism, lower the levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), reduce the expressions of interleukin-6 (IL-6) and interleuki n-10 (IL-10), and decrease diabetes-related liver damage. Moreover, the CCS and EDS altered the intestinal flora makeup in mice with T2DM. The abundance of Bacteroidota increased. Both types of chickpea RSs exhibited significant hypoglycaemic and hypolipidaemic effects, contributing to the reduction in inflammatory levels and the improvement in gut microbiota balance.